Eli Lilly and Company

Pharma / Pharma

Info

Overview Core Facts Blog Ratings Executives

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Balance Sheet

Pay attention and research significant changes from year to year values. [ ! ]

Fixed Column	Cash And Cash Equivalents	Short Term Investments	Cash And Short Term Investments	Net Receivables	Inventory	Other Current Assets	Total Current Assets	Property Plant Equipment Net	Goodwill	Intangible Assets	Goodwill And Intangible Assets	Long Term Investments	Tax Assets	Other Non Current Assets	Total Non Current Assets	Other Assets	Total Assets	Account Payables	Short Term Debt	Tax Payables	Deferred Revenue	Other Current Liabilities	Total Current Liabilities	Long Term Debt	Deferred Revenue Non Current	Deferred Tax Liabilities Non Current	Other Non Current Liabilities	Total Non Current Liabilities	Total Liabilities	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income Loss	Other Total Stockholders Equity	Total Stockholders Equity	Total Equity	Total Liabilities And Stockholders Equity	Minority Interest	Total Liabilities And Total Equity	Total Investments	Total Debt	Net Debt
2024-12	3268.4	0.0	3268.4	0.0	0.0	111.4	3518.4	17102.4	5770.3	6166.3	11936.6	3215.9	8000.6	5719.7	45975.2	29221.3	78714.89	0.0	0.0	0.0	0.0	28376.6	28376.6	0.0	0.0	0.0	36066.69	36066.69	64443.3	592.4	0.0	14240.0	-511.7	14320.7	14320.7	78714.89	0.0	78714.89	3215.9	33644.19	-3268.4
2023-12	2818.6	109.1	2927.7	11336.2	5772.8	5690.3	25727.0	12913.6	4939.7	6906.6	11846.3	3052.2	5477.3	4989.89	38279.3	0.0	64006.3	2598.8	6904.5	3849.2	0.0	13940.7	27293.2	18320.8	0.0	0.0	7528.6	25849.4	53142.6	593.6	10312.29	-4327.0	4193.0	10771.9	10863.7	64006.3	91.8	64006.3	3161.3	25225.3	22406.7
2022-12	2067.0	144.8	2211.8	8558.9	4309.7	2954.1	18034.5	10144.0	4073.0	7206.6	11279.6	2901.8	2792.9	4337.0	31455.3	0.0	49489.8	1930.6	1501.1	475.1	0.0	13231.4	17138.2	14737.5	0.0	87.3	6751.4	21576.2	38714.4	594.1	10042.6	-3844.6	6870.9	10649.8	10775.4	49489.8	125.6	49489.8	3046.6	16238.6	14171.6
2021-12	3818.5	90.1	3908.6	8127.2	3886.0	2530.6	18452.4	8985.1	3892.0	7691.9	11583.9	3212.6	2489.3	4082.7	30353.6	0.0	48806.0	1670.6	1538.3	126.9	8816.29	11716.9	15052.7	15346.4	5874.1	1733.7	7518.4	24598.5	39651.19	596.29	8958.5	-4343.1	6780.7	8979.2	9154.79	48806.0	175.6	48806.0	3302.7	16884.7	13066.2

Explore more balance sheet data for Eli Lilly and Company!

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.